North American E-Cigarette Market
North America's e-Cigarette Market Set to Explode at 18.2% CAGR, Reaching $31.3 Billion by 2028 - Market Shares by Product Type, Flavor Variation, Battery Operation Mode, and Distribution Channel Unveiled
January 31, 2024 03:59 ET | Research and Markets
Dublin, Jan. 31, 2024 (GLOBE NEWSWIRE) -- The "North America e-Cigarette Market: Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028" report has been added to ...
22157.jpg
Global E-Cigarette Markets, 2021-2022 & 2027: Shift towards Next Generation Products, Upswing in Gen Z Income, Rise in Technological Developments
September 13, 2022 05:33 ET | Research and Markets
Dublin, Sept. 13, 2022 (GLOBE NEWSWIRE) -- The "Global E-Cigarette Market: By Product Type, By Category, By Composition, By Distribution Channel, By Region Size & Forecast with Impact Analysis...
Global E-Cigarette Market
Insights on the E-Cigarette Global Market to 2027 - by Product, Flavor, Mode of Operation, Distribution Channel and Region
April 06, 2022 07:58 ET | Research and Markets
Dublin, April 06, 2022 (GLOBE NEWSWIRE) -- The "E-Cigarette Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2022-2027" report has been added to ResearchAndMarkets.com's...
22157.jpg
Global E-Cigarette Market Report 2021: Consumer Perception of a Safer Product v Traditional Cigarettes has Led to Increased Demand
April 22, 2021 07:48 ET | Research and Markets
Dublin, April 22, 2021 (GLOBE NEWSWIRE) -- The "E-Cigarette Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2021-2026" report has been added to ResearchAndMarkets.com's...
rtsl.jpg
Rapid Therapeutic Announces Completion of New ISO 13485 Laboratory
August 18, 2020 07:00 ET | Rapid Therapeutic Science Laboratories
DALLAS, Aug. 18, 2020 (GLOBE NEWSWIRE) -- Rapid Therapeutic Science Laboratories, Inc. (OTC: RTSL) an SEC fully-reporting, growth-oriented aerosol manufacturing and marketing company focused on...
rtsl.jpg
Rapid Therapeutic Science Laboratories (RTSL), Inc. engages Ezzey Digital Marketing Agency to Launch its New Lifestyle Brand “nhāler”
August 06, 2020 07:00 ET | Rapid Therapeutic Science Laboratories
DALLAS, Aug. 06, 2020 (GLOBE NEWSWIRE) -- Rapid Therapeutic Science Laboratories, Inc. (OTC: RTSL), an SEC fully-reporting, growth-oriented manufacturing and marketing company focused on employing...
rtsl.jpg
Rapid Therapeutic Completes Delivery of Additional 6,000 Units of its Proprietary Metered Dose Inhalers DALLAS, July 14, 2020 (GLOBE NEWSWIRE) -- Rapid Therapeutic Science Laboratories, Inc. (OTC: RTSL) an SEC fully-reporting, growth-oriented manufacturing and marketing company focused on employing...
rtsl.jpg
Rapid Therapeutic Announces Major Contract is Increased by 150% to 250,000 Metered Dose Inhalers DALLAS, July 09, 2020 (GLOBE NEWSWIRE) -- Rapid Therapeutic Science Laboratories, Inc. (OTC: RTSL), a fully-reporting, early stage, emerging biotech company focused on aerosol delivery of...
rtsl.jpg
Rapid Therapeutic Completes Initial Delivery of 2,000 Units of its Proprietary Metered Dose Inhalers DALLAS, July 08, 2020 (GLOBE NEWSWIRE) -- Rapid Therapeutic Science Laboratories, Inc. (OTC: RTSL) an SEC fully-reporting, growth-oriented company focused on manufacturing and marketing aerosol...
Rapid Therapeutic Science Laboratories, Inc. Highlighted in Research Report Released by Emerald Equity Research, LLC
June 22, 2020 08:30 ET | Rapid Therapeutic Science Laboratories
DALLAS, June 22, 2020 (GLOBE NEWSWIRE) -- Rapid Therapeutic Science Laboratories, Inc. (OTC: RTSL) an SEC fully-reporting, growth-oriented company focused on manufacturing and marketing CBD aerosol...